- Home
- BIRK vs PCVX Comparison
BIRK vs PCVX Comparison
Compare BIRK & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIRK
- PCVX
- Stock Information
- Founded
- BIRK 1774
- PCVX 2013
- Country
- BIRK United Kingdom
- PCVX United States
- Employees
- BIRK N/A
- PCVX N/A
- Industry
- BIRK
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- BIRK
- PCVX Health Care
- Exchange
- BIRK Nasdaq
- PCVX Nasdaq
- Market Cap
- BIRK 8.8B
- PCVX 4.4B
- IPO Year
- BIRK 2023
- PCVX 2020
- Fundamental
- Price
- BIRK $48.82
- PCVX $33.25
- Analyst Decision
- BIRK Strong Buy
- PCVX Strong Buy
- Analyst Count
- BIRK 10
- PCVX 10
- Target Price
- BIRK $69.00
- PCVX $136.50
- AVG Volume (30 Days)
- BIRK 1.9M
- PCVX 1.5M
- Earning Date
- BIRK 08-28-2025
- PCVX 08-05-2025
- Dividend Yield
- BIRK N/A
- PCVX N/A
- EPS Growth
- BIRK 152.58
- PCVX N/A
- EPS
- BIRK 1.45
- PCVX N/A
- Revenue
- BIRK $2,114,754,647.00
- PCVX N/A
- Revenue This Year
- BIRK $19.19
- PCVX N/A
- Revenue Next Year
- BIRK $15.95
- PCVX N/A
- P/E Ratio
- BIRK $33.62
- PCVX N/A
- Revenue Growth
- BIRK 19.89
- PCVX N/A
- 52 Week Low
- BIRK $40.56
- PCVX $27.66
- 52 Week High
- BIRK $64.78
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- BIRK 33.97
- PCVX 45.61
- Support Level
- BIRK $48.34
- PCVX $32.00
- Resistance Level
- BIRK $50.28
- PCVX $34.63
- Average True Range (ATR)
- BIRK 1.33
- PCVX 1.33
- MACD
- BIRK -0.40
- PCVX -0.06
- Stochastic Oscillator
- BIRK 9.70
- PCVX 33.67
About BIRK Birkenstock Holding plc
Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.